Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07525947
PHASE1

A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants

Sponsor: Jade Biosciences, Inc.

View on ClinicalTrials.gov

Summary

This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of JADE101 in healthy Japanese and Chinese participants.

Official title: A Phase 1, Open-label, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JADE101 Administered Subcutaneously in Healthy Japanese and Chinese Participants.

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2026-05

Completion Date

2027-05

Last Updated

2026-04-15

Healthy Volunteers

Yes

Interventions

DRUG

JADE101

JADE101 is supplied as sterile solution to be administered by SC injection

Locations (1)

Parexel Early Phase Clinical Unit (EPCU)

Glendale, California, United States